Vishal Chavda | Clinical Neuroscience| Neuroscience Future Leader Award

Published on by Neuroscientists

Dr. Vishal Chavda | Clinical Neuroscience | Neuroscience Future Leader Award

Dr. Vishal Chavda | Department of Neurology, Miami Miller School of Medicine, Miami | United States

Vishal K. Chavda, Ph.D., M.S., PG.Dip (Clinical Psychology), FICN, MAHA/ASA, is a neuroscientist and neuropharmacologist with multidisciplinary expertise in neurology, neurosurgery, and neuropathology, currently serving as a Postdoctoral Associate in the Department of Neurology, Division of Interventional Neurology and Endovascular Neurosurgery at the University of Miami Miller School of Medicine, and previously as a Postdoctoral Fellow in Neuropathology at Stanford University School of Medicine, with international experience as a Visiting Fellow in Neurosurgery at the Gamma Knife Center, Garibaldi Cannizzaro Hospital, Italy. He earned his Ph.D. in Neuropharmacology from Nirma University and has held prestigious fellowships supported by CSIR, Government of India. His research focuses on ischemic and pediatric stroke, endovascular stem cell therapy, traumatic brain injury, glioblastoma and brain metastasis, neurovascular conflict syndromes and aneurysms, vesicular trafficking in stroke, epilepsy, cognitive decline, neurodegeneration including Alzheimer’s disease, and computational in-silico modeling. Dr. Chavda has authored over 30 peer-reviewed scientific documents, accumulating more than 1,347 citations, with an h-index of 20 and an i10-index exceeding 30, reflecting the strong impact and visibility of his work in clinical and translational neuroscience. He is actively seeking a research or academic position to advance innovative therapies and mechanistic insights in neurovascular and neurodegenerative disorders.

Citation Metrics (Google Scholar)

1500
1000
500
0

Citations
1347

Documents
30

h-index
20

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications

Cerebrospinal fluid volume: the overlooked determinant in brain and spinal stroke
– V Chavda, CM Stary, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7956–7957, 2025

Persistent pelvic pain in women: unraveling diagnostic challenges and the overlooked role of pelvic congestion syndrome
– V Chavda, B Joshi, AD Bhatt, S Patel, M Savaliya, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7950–7952, 2025

Redefining Access: A Syringe-Based Tubular Retractor for Minimally Invasive Spine Surgery in Low-Resource Settings
– G Reyes-Soto, DAV Moreno, R Nurmukhametov, V Chavda, SN Comprehensive Clinical Medicine, 7(1), 310, 2025

Preventing spina bifida in low- and middle-income countries: bridging gaps through folic acid fortification and policy reform
– MK Vatse, V Chavda, YB Roka, B Chaurasia, Annals of Medicine and Surgery, 87(10), 6263–6264, 2025

Association between vitamin D deficiency and subarachnoid hemorrhage: a systematic review
– VO da Silva, RP Manicardi, JS Brito, MG de Sena Barbosa, LZ Pipek, V Chavda, Annals of Medicine and Surgery, 87(10), 6443–6450, 2025

Qing Ye | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Qing Ye | Clinical Neuroscience | Best Researcher Award

Dr. Qing Ye | Tianjin University Central Hospital | China

Qing Ye, MD, is a Chief Physician and Deputy Director in the Department of Digestive and Hepatology at Tianjin Third Central Hospital, where he has devoted nearly two decades to the diagnosis and management of chronic liver diseases and their complications. He earned his bachelor’s degree from Shandong Medical University, followed by a master’s degree and an MD from Tianjin Medical University, and further broadened his academic vision as a visiting scholar at Stanford University. His clinical and research interests span chronic hepatitis B, alcoholic and nonalcoholic fatty liver disease, metabolic dysfunction–associated steatotic liver disease, autoimmune liver disease, cirrhosis, ascites, portal hypertension, esophageal and gastric variceal bleeding, and liver failure. Dr. Ye has made significant contributions to understanding metabolic abnormalities in liver disease, gaps in hepatitis B care, and the global burden of lean NAFLD, with first-author publications in leading journals such as Frontiers in Immunology, Frontiers in Endocrinology, Journal of Hepatology, HepatoBiliary Surgery and Nutrition, and The Lancet Gastroenterology & Hepatology. His work has achieved wide international recognition, reflected by an h-index of 8, a total of 22 published documents, and 1,681 citations, underscoring his impact on advancing evidence-based hepatology and improving outcomes for patients with chronic liver disease.

Citation Metrics (Scopus)

2000
1500
1000
0

Citations
1,681

Documents
22

h-index
8

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Kaiser Permanente of Georgia, Emory School of Medicine | United States

Dr. Joshua I. Barzilay is a senior clinician–scientist and board-certified endocrinologist whose research spans diabetes, hypertension, cardiovascular disease, metabolic syndrome, and aging, integrating epidemiology with long-term clinical outcomes. His early work included oncology and hematology research, followed by a sustained focus on endocrine and metabolic disorders during his tenure at Kaiser Permanente of Georgia and Emory University School of Medicine. Dr. Barzilay has made influential contributions to large, multicenter clinical and population-based studies, including ALLHAT, ACCORD/ACCORDION, and the Cardiovascular Health Study, where he has served on steering committees and specialty working groups. His research has clarified the impact of glucose dysregulation, insulin resistance, and antihypertensive therapies on cardiovascular morbidity, mortality, and incident diabetes, particularly in older adults. A major theme of his work is the relationship between metabolic syndrome, frailty, autonomic function, and cardiovascular risk, providing evidence to guide treatment strategies in complex patients. In addition to his research, Dr. Barzilay has played a key role in national diabetes and hypertension guideline development, medical education, and dissemination of evidence-based care, shaping clinical practice across endocrinology and primary care.

Citation Metrics (Scopus)

25000
20000
15000
10000
0

Citations
24,155

Documents
186
h-index
58

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile

Featured Publications